32 studies found for:    Open Studies | "Giant Cell Arteritis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Giant Cell Arteritis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Tocilizumab for Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: Tocilizumab + Glucocorticoids (GCs);   Drug: Placebo + Glucocorticoids (GCs)
2 Unknown  Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis
Conditions: Takayasu's Arteritis;   Giant Cell Arteritis;   Arteritis;   Vasculitis;   Aortitis
Intervention:
3 Not yet recruiting Study of Circulating Microparticles in Giant Cell Arteritis
Conditions: Giant Cell Arteritis;   Acute Phase
Intervention: Other: Blood sample
4 Recruiting Prospective Follow-up Study of the Aortic Diameter in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention:
5 Recruiting A Study of RoActemra/Actemra (Tocilizumab) in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: prednisone;   Drug: prednisone placebo;   Drug: tocilizumab placebo;   Drug: tocilizumab [RoActemra/Actemra]
6 Recruiting Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
Condition: Temporal Arteritis
Intervention:
7 Recruiting Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL)
Condition: Giant Cell Arteritis
Interventions: Procedure: Ultrasound of temporal and axillary arteries;   Procedure: Temporal artery biopsy
8 Unknown  Efficacy of Micro-Pulse Steroid Therapy as Induction Therapy in Patients With Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Interventions: Drug: Betamethasone;   Drug: isotonic sodium chloride solution (placebo)
9 Recruiting Study of the T CD8 Immune Response in Horton's Disease
Condition: Horton's Disease
Interventions: Other: Blood sample drawn into a 5 mL dry tube at the diagnosis and after 3 months of treatment;   Other: 16 blood samples drawn into 6 mL heparinized tubes at the diagnosis and after 3 months of treatment;   Other: Blood sample drawn into a 5 mL dry tube;   Other: 16 blood samples drawn into 6 mL heparinized tubes
10 Recruiting Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)
Conditions: Horton's Disease;   Infectious Disease;   Neoplasia;   Solid Tumor;   Hemopathy
Interventions: Other: 1 blood sample;   Other: 2 to 3 blood samples (at inclusion, at 3 months and at 6 months in cases of relapse)
11 Unknown  Diagnostic Study of Temporal Arteritis
Condition: Temporal Arteritis
Intervention:
12 Unknown  Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis
Conditions: Temporal Arteritis;   Duplex of Temporal Artery;   Biopsy of Temporal Artery
Intervention: Procedure: biopsy of temporal artery
13 Recruiting American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
Conditions: Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg Strauss Syndrome;   Polyarteritis Nodosa;   Giant Cell Arteritis;   Takayasu Arteritis
Intervention:
14 Recruiting One-Time DNA Study for Vasculitis
Conditions: Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss);   Giant Cell Arteritis;   Granulomatosis With Polyangiitis (Wegener's);   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu's Arteritis
Intervention:
15 Recruiting Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Horton's Disease: Proof of Concept Study.
Condition: Horton's Disease
Intervention: Drug: corticoids+ tocilizumab 8mg/Kg/month
16 Not yet recruiting Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis
Conditions: Dermatomyositis;   Juvenile Dermatomyositis
Intervention: Drug: H.P. Acthar Gel
17 Unknown  Creatine Supplementation in Pediatric Rheumatology
Conditions: Juvenile Systemic Lupus Erythematosus;   Juvenile Dermatomyositis
Interventions: Dietary Supplement: creatine;   Dietary Supplement: placebo (dextrose)
18 Unknown  Abatacept Treatment in Polymyositis and Dermatomyositis
Conditions: Polymyositis;   Dermatomyositis
Intervention: Drug: Abatacept
19 Available Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes
Conditions: Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE);   Juvenile Dermatomyositis (JDM);   Stimulator of Interferon Genes (STING)-Associated Vasculitis With Onset in Infancy (SAVI)
Intervention: Drug: Baricitinib
20 Unknown  Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis
Condition: Juvenile Dermatomyositis
Interventions: Drug: 3 MPDN pulse + PDN;   Drug: 3 MPDN pulse + PDN + CSA;   Drug: 3 MPDN pulse + PDN + MTX

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Indicates status has not been verified in more than two years